New in Dermatology from The Outside World: From Grey Hair to Melanoma Vaccine Therapies
This is the first edition of a quarterly column highlighting articles of interest to dermatologists from non-dermatologic literature. It is already difficult to keep up to date with the high volume and forever expanding literature in dermatologic journals. Additionally, it is virtually impossible to read the full breadth of biomedical literature for materials relevant to the field of dermatology. …
This is the first edition of a quarterly column highlighting articles of interest to dermatologists from non-dermatologic literature. It is already difficult to keep up to date with the high volume and forever expanding literature in dermatologic journals. Additionally, it is virtually impossible to read the full breadth of biomedical literature for materials relevant to the field of dermatology. … 
Mutations in which gene would likely be found in the neoplastic cells of this lesion?
A. PATCH
B. p53
C. Fumarate hydratase
D. CREBBP
E. p63
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
CASE
A 47-year-old woman presented for Mohs Micrographic Surgery for a biopsy-proven basal cell carcinoma involving the right nasal ala. The patient had a history of basal cell nevus syndrome (BCNS) and previous history of multiple basal cell carcinomas.
On initial examination, the patient was noted to have a few scattered pearly molluscoid papules on the head and neck, which were suspicio … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
As states begin easing restrictions, this month’s Patient Buzz includes several articles on how to care for the skin post-quarantine. Are mask-off injectable treatments safe for patients and providers? What skin, hair and nail concerns need an in-person visit, and what can be addressed virtually? How will COVID-19 for … 
Melanoma remains the most common cause of death among skin cancers. Over the past decade, major leaps have been made in treating advanced melanoma, resulting in unprecedented improvement in survival. Nevertheless, a large room for improvement is still ahead. In his presentation Therapeutic Updates in Melanoma: IO for Earlier Stage Disease presented at the 2020 ODAC Dermatology, Aesthetic and Sur …